Advisory Committees

Transmissible Spongiform Encephalopathies Advisory Committee

The Transmissible Spongiform Encephalopathies Advisory Committee was terminated on June 9, 2016. For more information, please refer to the Federal Register Notice FR Document Number 2016-13705 that was published on June 9, 2016.

All topics previously brought before the terminated Transmissible Spongiform Encephalopathies Advisory Committee will now be addressed by the Food and Drug Administration's other advisory committees, such as the Blood Products Advisory Committee (BPAC).

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 06/09/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English